717080.fig.001a
(a)
717080.fig.001b
(b)
717080.fig.001c
(c)
717080.fig.001d
(d)
Figure 1: Ki-67% at (a) increasing PSA ranges, (b) clinical T stages, (c) increasing Gleason scores, and (d) NCCN risk groups.